Marc Delclos, M.D.

Peer-Reviewed Articles

1. Gunther JR, Chadha AS, Guha S, Raju GS, Maru DM, Munsell MF, Jiang Y, Yang P, Felix E, Clemons M, Mathew GG, Singh PK, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Eng C, Delclos ME, Crane CH, Das P, Krishnan S. A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer. J Gastrointest Oncol 13(6):2938-2950, 2022. PMID: 36636059.
2. Holliday EB, Morris VK, Johnson B, Eng C, Ludmir EB, Das P, Minsky BD, Taniguchi C, Smith GL, Koay EJ, Koong AC, Delclos ME, Skibber JM, Rodriguez-Bigas MA, You YN, Bednarski BK, Tillman MM, Chang GJ, Jennings K, Messick CA. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. Oncologist 27(1):40-47, 2022. PMID: 35305097.
3. Gunther JR, Chadha AS, Shin US, Park IJ, Kattepogu KV, Grant JD, Weksberg DC, Eng C, Kopetz SE, Das P, Delclos ME, Kaur H, Maru DM, Skibber JM, Rodriguez-Bigas MA, You YN, Krishnan S, Chang GJ.. Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis. Adv Radiat Oncol, 2017.
4. 1. Chadha AS, Liu G, Chen H-C, Das P, Minsky BD, Mahmood U, Delclos ME, Suh Y, Sawakuchi GO, Beddar S, Katz MH, Fleming JB, Javle MM, Varadhachary GR, Wolff RA, Crane CH, Wang X, Thames H, Krishnan S. Does unintentional splenic radiation predict severe lymphopenia following pancreatic cancer radiotherapy?. Int J Radiat Oncol Biol Phys. e-Pub 2017.
5. Tao R, Tsai CJ, Jensen G, Eng C, Kopetz S, Overman MJ, Skibber JM, Rodriguez-Bigas M, Chang GJ, You YN, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P.. Hyperfractionated accelerated reirradiation for rectal cancer: An analysis of outcomes and toxicity. Radiother Oncol. e-Pub 2017.
6. Osborne EM, Eng C, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Nancy You YQ, Bednarski BK, Minsky BD, Delclos ME, Koay E, Krishnan S, Crane CH, Das P.. Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation. Am J Clin Oncol, 2016.
7. Awalpreet S Chadha; Heath D Skinner; Jillian R Gunther; Mark F Munsell; Prajnan Das; Bruce D Minsky; Marc E Delclos; Deyali Chatterjee; Huamin Wang; Marilyn Clemons; Geena George; Pankaj K Singh; Matthew H Katz; Jason B Fleming; Milind M Javle; Robert A Wolff; Gauri R Varadhachary; Christopher H Crane; Sunil Krishnan. Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLOS ONE, 2016.
8. Nikhil G. Thaker, MD, Laurie Sturdevant, RN, OCN, Anuja Jhingran, MD, Prajnan Das, MD, MS, MPH, Marc E. Delclos, MD, Gary B. Gunn, MD, Mary Frances McAleer, MD, PhD, Welela Tereffe, MD, MPH, Seungtaek L. Choi, MD, Steven J. Frank, MD, William J. Simeone Jr, MHA, Wendi Martinez, RN, OCN, Stephen M. Hahn, MD, Robin Famiglietti, MBA, and Deborah A. Kuban, MD. Assessing the Quality of a Radiation Oncology Case-based Peer-review Program in an Integrated Academic and Community Cancer Center Network. Journal of Oncology Practice, 2016.
9. Sunil Krishnan, M.Dcorrespondence∗email, Awalpreet S. Chadha, M.D∗, Yelin Suh, Ph.D, Prajnan Das, M.D, Bruce D. Minsky, M.D, Usama Mahmood, M.D, Marc E. Delclos, M.D, Gabriel O. Sawakuchi, Ph.D, Sam Beddar, Ph.D, Matthew H. Katz, M.D, Jason B. Fleming, M.D, Milind M. Javle, M.D, Gauri R. Varadhachary, M.D, Robert A. Wolff, M.D, Christopher H. Crane, M.D. Focal radiotherapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation. International Journal of Radiation Oncology Biology/Physics, 2016.
10. 3. Das P, Cantor SB, Parker CL, Zampieri JB, Baschnagel A, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH. Quality of Life after Intensity Modulated Radiation Therapy For Anal Cancer. Journal of Radiation Oncology, 2015.
11. Chadha AS, Kocak-Uzel E, Das P, Minsky BD, Delclos ME, Mahmood U, Guha S, Ahmad M, Varadhachary GR, Javle M, Katz MH, Fleming JB, Wolff RA, Crane CH, Krishnan S. Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Acta Oncol 54(7):971-8, 2015. e-Pub 2015. PMID: 25608822.
12. Deborah Kuban, Nikhil G Thaker, Laurie Sturdevant, Anuja Jhingran, Prajanan Das, Marc E Delclos, Gary B Gunn, Mary Frances McAleer, Welela Tereffe, Seungtaek L Choi, William J Simeone Jr, Wendi Martinez, Stephen M Hahn and Robin Famiglietti. Assessing the Quality of a Radiation Oncology Case Based Peer-Review Program in an Integrated Academic and Community Cancer Center Network, 2015.
13. Ashleigh M Francis MD1; Ching-Wei D. Tzeng MD2; John R. Hyngstrom MD3; Sam Beddar, PhD4; Prajnan Das MD, MPH5; Sunil Krishnan MD5; Bruce D. Minsky MD5; Christopher H. Crane MD5; Marc E. Delclos, MD5; John M. Skibber MD, FACS1; George J. Chang MD, FACS, MS1; Y. Nancy You MD1; Barry W. Feig, MD1; Miguel A. Rodriguez-Bigas MD, FACS, FASCRS1. Local Control and Surgical Decision-Making When Choosing Intraoperative Radiation Therapy (IORT) for Locally Advanced Colorectal Cancer: An Analysis of 178 Patients Intended to Undergo IORT, 2015.
14. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol 109(7):652-8, 2014. e-Pub 2014. PMID: 24510523.
15. Rogers JE, Crane CH, Das P, Delclos M, Gould MS, Ohinata A, Malatek D, Eng C. Definitive chemoradiation in oligometastatic squamous cell carcinoma of the anal canal. Gastrointest Cancer Res 7(2):65-8, 2014. PMID: 24799976.
16. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys 88(2):301-5, 2014. e-Pub 2013. PMID: 24315563.
17. Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Gastric Bleeding After Radiation Therapy for Intrahepatic Cholangiocarcinoma. Prac Radiat Oncol, 2013.
18. Mitchell MP, Abboud M, Eng C, Beddar AS, Krishnan S, Delclos ME, Crane CH, Das P. Intensity-Modulated Radiation Therapy with Concurrent Chemotherapy for Anal Cancer: Outcomes and Toxicity. Am J Clin Oncol. e-Pub 2013. PMID: 23466576.
19. Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH. Duodenal Toxicity After Fractionated Chemoradiation for Unresectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys 85(3):e143-149, 2013. e-Pub 2012. PMID: 23200173.
20. Briere TM, Crane CH, Beddar S, Bhosale P, Mok H, Delclos ME, Krishnan S, Das P. Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients. Radiother Oncol 104(2):161-166, 2012. e-Pub 2012. PMID: 22841019.
21. Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P. Intensity-Modulated Radiation Therapy with Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma. Int J Radiat Oncol Biol Phys 83(2):581-586, 2012. e-Pub 2011. PMID: 22137021.
22. Suzuki A, Xiao L, Taketa T, Blum MA, Matamoros A, Chien PL, Mansfield PF, Fournier KF, Weston B, Lee JH, Bhutani MS, Estrella JS, Delclos ME, Krishnan S, Das P, Ajani JA. Localized Gastric Cancer Treated with Chemoradation without Surgery: UTMD Anderson Cancer Center Experience. Oncology 82(6):347-351. e-Pub 2012. PMID: 22677933.
23. Kelly P, Das P, Varadhachary GR, Fontanilla HP, Krishnan S, Delclos ME, Jhingran A, Eifel PJ, Crane CH. Role of Definitive Radiation Therapy in Carcinoma of Unknown Primary in the Abdomen and Pelvis. Int J Radiat Oncol Biol Phys 82(5):2012-2017, 2012. e-Pub 2011. PMID: 21640510.
24. Skinner HD, Sharp HJ, Kaseb AO, Javle MM, Vauthey JN, Abdalla EK, Delclos ME, Das P, Crane CH, Krishnan S. Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 50(8):1191-1198, 2011. e-Pub 2011. PMID: 21793641.
25. Mok H, Briere TM, Martel MK, Beddar S, Delclos ME, Krishnan S, Crane CH, Das P. Comparative analysis of volumetric modulated arc therapy versus intensity modulated radiation therapy for radiotherapy of anal carcinoma. Prac Radiat Oncol 1(3):163-172, 2011.
26. Dabaja BS, Rebueno NC, Mazloom A, Thorne S, Perrin KJ, Tolani N, Das P, Delclos ME, Iyengar P, Reed VK, Horace P, Salehpour MR. Radiation for Hodgkin's Lymphoma in Young Female Patients: A New Technique to Avoid the Breasts and Decrease the Dose to the Heart. Int J Radiat Oncol Biol Phys 79(2):503-507, 2011. e-Pub 2010. PMID: 20418023.
27. Mok H, Crane CH, Palmer MB, Briere TM, Beddar S, Delclos ME, Krishnan S, Das P. Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. Radiat Oncol 6:63, 2011. e-Pub 2011. PMID: 21651775.
28. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Bedi M, Krishnan S, Crane CH. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 77(1):60-65, 2010. e-Pub 2009. PMID: 19695792.
29. Das P, Cantor SB, Parker CL, Zampieri JB, Baschnagel A, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH. Long-term quality of life after radiotherapy for the treatment of anal cancer. Cancer 116(4):822-829, 2010. PMID: 20041481.
30. Park HC, Janjan NA, Mendoza TR, Lin EH, Vadhan-Raj S, Hundal M, Zhang Y, Delclos ME, Crane CH, Das P, Wang XS, Cleeland CS, Krishnan S. Temporal Patterns of Fatigue Predict Pathologic Response in Patients Treated with Preoperative Chemoradiation Therapy for Rectal Cancer. Int J Radiat Oncol Biol Phys 75(3):775-781, 2009. e-Pub 2009. PMID: 19231100.
31. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity-Modulated Radiation Therapy for the Treatment of Squamous Cell Anal Cancer with Para-aortic Nodal Involvement. Int J Radiat Oncol Biol Phys 75(3):791-794, 2009. e-Pub 2009. PMID: 19231109.
32. Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, Delclos ME, Feig BW. Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer. Ann Surg Oncol 17(2):441-447, 2009. e-Pub 2009. PMID: 19847569.
33. Herman MP, Kopetz S, Bhosale PR, Eng C, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Janjan NA, Delclos ME, Krishnan S, Crane CH. Sacral insufficiency fractures after preoperative chemoradiation for rectal cancer: Incidence, risk factors and clinical course. Int J Radiat Oncol Biol Phys 74(3):818-823. e-Pub 2009. PMID: 19147305.
34. Haque W, Crane CH, Krishnan S, Delclos ME, Javle M, Garrett CR, Wolff RA, Das P. Reirradiation to the abdomen for gastrointestinal malignancies. Radiat Oncol 4:55, 2009. PMID: 19922641.
35. Reed VK, Krishnan S, Mansfield PF, Bhosale PR, Kim M, Das P, Janjan NA, Delclos ME, Lowy AM, Feig BW, Pisters PW, Ajani JA, Crane CH. Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 71(3):741-747, 2008. e-Pub 2007. PMID: 18164837.
36. Yu TK, Bhosale PR, Crane CH, Iyer RB, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Das P. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 71(4):1175-1180, 2008. e-Pub 2008. PMID: 18207667.
37. Kim MM, Mansfield PF, Das P, Janjan NA, Badgwell BD, Phan AT, Delclos ME, Maru D, Ajani JA, Crane CH, Krishnan S. Chemoradiation therapy of potentially resectable gastric cancer: clinical outcomes among patients who do not undergo planned surgery. Int J Radiat Oncol Biol Phys 71(1):167-172, 2008.
38. Kim MM, Rana V, Janjan NA, Das P, Phan AT, Delclos ME, Mansfield PF, Ajani JA, Crane CH, Krishnan S. Clinical benefit of palliative radiation therapy in advanced gastric cancer. Acta Oncol 47(3):421-427, 2008. e-Pub 2007. PMID: 17899453.
39. Krishnan S, Rana V, Evans DB, Varadhachary G, Das P, Bhatia S, Delclos ME, Janjan NA, Wolff RA, Crane CH, Pisters PW. Role of Adjuvant Chemoradiation Therapy in Adenocarcinomas of the Ampulla of Vater. Int J Radiat Oncol Biol Phys 70(3):735-743, 2008. e-Pub 2007.
40. Gao S, Delclos ME, Tomas LC, Crane CH, Beddar S. High dose rate remote afterloaders for intraoperative radiation therapy. AORN 86(5)(5):827-840, 2007. PMID: 18050890.
41. Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 68:794-800, 2007. PMID: 17379452.
42. Krishnan S, Rana V, Janjan NA, Varadhachary GR, Abbruzzese JL, Das P, Delclos ME, Gould MS, Evans DB, Wolff RA, Crane CH. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 110(1):47-55, 2007. e-Pub 2008. PMID: 17538975.
43. Beddar AS, Krishnan S, Briere TM, Wang X, Delclos ME, Ballo MT, Das P, Gould S, Horton JL, Crane CH. The optimization of dose delivery for intraoperative high-dose-rate radiation therapy using curved HAM applicators. Radiother Oncol 78(2):207-212, 2006. PMID: 16376445.
44. Crane CH, Ellis LM, Abbruzzese JL, Amos C, Xiong HQ, Ho L, Evans DB, Tamm EP, Ng C, Pisters PW, Charnsangavej C, Delclos ME, O'Reilly M, Lee JE, Wolff RA. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol 24:1145-1151, 2006. PMID: 16505434.
45. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 66:1378-1383, 2006. PMID: 17056196.
46. Das P, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Janjan NA, Delclos ME, Krishnan S, Levy LB, Ellis LM, Crane CH. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol 29(3):219-224, 2006. PMID: 16755173.
47. Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH. Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. Radiat Oncol 1:41, 2006. PMID: 17062148.
48. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 66(3):762-771, 2006. PMID: 17011451.
49. Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, Das P, Delclos ME, Janjan NA, Crane CH. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol 29(6):562-567, 2006. PMID: 17148992.
50. Krishnan S, Rana V, Janjan NA, Abbruzzese JL, Gould MS, Das P, Delclos ME, Palla S, Guha S, Varadhachary G, Evans DB, Wolff RA, Crane CH. Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer 107(11):2589-2596, 2006. PMID: 17083124.
51. Lin EH, Curley SA, Crane CC [sic], Feig B, Skibber J, Delclos M, Vadhan SR, Morris J, Ayers GD, Ross A, Brown T, Rodriguez-Bigas MA, Janjan N. Retrospective study of capecitabine and celecoxib in metastic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?. Am J Clin Oncol 29(3):232-239, 2006.
52. Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JM. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49(2):175-182, 2006.
53. Wong AA, Delclos ME, Wolff RA, Evans DB, Abbruzzese JL, Tamm EP, Xiong HQ, Ho L, Crane CH. Radiation dose considerations in the palliative treatment of locally advanced adenocarcinoma of the pancreas. Am J Clin Oncol 28(3):227-233, 2005. PMID: 15923793.
54. Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane C, Janjan N, Skibber JM. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 8(1):56-62; discussion 62-63, 2004. PMID: 14746836.
55. Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 60(4):1098-1105, 2004. PMID: 15519780.
56. Crane CH, Ellis LM, O'Reilly M, Ho L, Abbruzzese JL, Evans DB, Ng C, Charnsangavej C, Tamm EP, Xiong HQ, Delclos ME, Wolff RA. RhuMab VEGF (Bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer: an active, well tolerated regimen. Int J Radiat Oncol Biol Phys 60:S149, 2004.
57. Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, Lin EH, Fleshman JW, Thames HD, Kodner IJ, Lockett MA, Picus J, Phan T, Chandra A, Janjan NA, Read TE, Myerson RJ. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57(1):84-89, 2003. PMID: 12909219.
58. Crane CH, Skibber JM, Feig BW, Vauthey JN, Thames HD, Curley SA, Rodriguez-Bigas MA, Wolff RA, Ellis LM, Delclos ME, Lin EH, Janjan NA. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97(2):517-524, 2003. PMID: 12518377.
59. Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index. Cancer 97(5):1195-1202, 2003. PMID: 12599225.
60. Papagikos M, Crane CH, Skibber J, Janjan NA, Feig B, Rodriguez-Bigas MA, Hung A, Wolff RA, Delclos M, Lin E, Cleary K. Chemoradiation for adenocarcinoma of the anus. Int J Radiat Oncol Biol Phys 55(3):669-778, 2003. PMID: 12573754.
61. Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?. Int J Radiat Oncol Biol Phys 52(5):1293-1302, 2002. PMID: 11955742.
62. Crane CH, Macdonald KO, Vauthey JN, Yehuda P, Brown T, Curley S, Wong A, Delclos M, Charnsangavej C, Janjan NA. Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys 53(4):969-974, 2002. PMID: 12095564.
63. Janjan N, Crane C, Delclos M, Ballo M. Brachytherapy for locally recurrent soft-tissue sarcoma. Am J Clin Oncol 25(1):9-15, 2002. PMID: 11823688.
64. Kelly JF, Delclos ME, Morice RC, Huaringa A, Allen PK, Komaki R. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience. Int J Radiat Oncol Biol Phys 48(3):697-702, 2000. PMID: 11020566.
65. Komaki R, Roth JA, Walsh GL, Putnam JB, Vaporciyan A, Lee JS, Fossella FV, Chasen M, Delclos ME, Cox JD. Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 48(2):347-354, 2000. PMID: 10974447.
66. Delclos ME, Komaki R, Morice RC, Allen PK, Davis M, Garden A. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Radiology 201(1):279-282, 1996. PMID: 8816560.

Invited Articles

1. Briere TM, Krishnan S, Pan T, Ng C, Balter P, Tolani N, Starkschall G, Janjan N, Delclos M, Das P, Crane C, Beddar S. 4D-CT imaging with synchronized IV contrast for the treatment planning of liver tumors. European Society of Therapeutic Radiology and Oncology, Leipzig, Germany, 2008.
2. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity modulated radiation therapy (IMRT) for the treatment of squamous cell anal cancer in patients with prior pelvic irradiation, Prog/Proc 2008 Gastrointestinal Cancers Symposium:317. Int J Rad Oncol Biol Phys, 2008.
3. Delclos M, Krishnan S, Mendoza T, Lin E, Vadhan-Raj S, Das P, Crane C, Zhang Y, Cleeland C, Janjan N. Baseline and temporal patterns of fatigue predict pathological response in patients treated with preoperative chemoradiation therapy of rectal cancer. J Clin Oncol 25(18S):626S, 2007.
4. Janjan NA, Wang XS, Mendoza T, Zhang Y, Das P, Crane C, Delclos M, Krishnan S. Utility of the M. D. Anderson Symptom Assessment Inventory (MDASI) for symptom evaluation during chemoradiation in patients with gastrointestinal malignancies. J Clin Oncol 25(18S):350S, 2007.
5. Crane, CH, Ellis LM, Xiong HQ, O'Reilly M, Delclos ME, Abbruzzese JL, Evans DB, Pisters PWT, Wolff RA. Preliminary results of a phase I study of rhumab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. Eur J Cancer 1:S294 (#980), 2007.

Abstracts

1. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol 109(7):652-8, 2014. e-Pub 2014. PMID: 24510523.
2. Rogers JE, Crane CH, Das P, Delclos M, Gould MS, Ohinata A, Malatek D, Eng C. Definitive chemoradiation in oligometastatic squamous cell carcinoma of the anal canal. Gastrointest Cancer Res 7(2):65-8, 2014. PMID: 24799976.
3. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, You YN, Maru DM, Munsell MF, Clemons MV, Kopetz SE, Garrett CR, Shureiqi I, Delclos ME, Krishnan S, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal cancer: a phase 1 trial. Int J Radiat Oncol Biol Phys 88(2):301-5, 2014. e-Pub 2013. PMID: 24315563.
4. Eng C, Chang GJ, You YN, Das P, Xing Y, Delclos M, Wolff RA, Rodriguez-Bigas MA, Skibber J, Ohinata A, Gould S, Phillips J, Crane CH. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal. Cancer 119(21):3769-75, 2013. e-Pub 2013. PMID: 24037775.
5. Skinner HD, Crane CH, Garrett CR, Eng C, Chang GJ, Skibber JM, Rodriguez-Bigas MA, Kelly P, Sandulache VC, Delclos ME, Krishnan S, Das P. Metformin use and improved response to therapy in rectal cancer. Cancer Med 2(1):99-107, 2013. e-Pub 2013. PMID: 24133632.
6. Sturgeon JD, Crane C, Krishnan S, Delclos M, Eng C, Das P. Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum. Int J Radiat Oncol Biol Phys 84(3S):S349, 2012.
7. Tzeng C, Hyngstrom JR, Beddar AS, Delclos ME, Crane CH, Krishnan S, Das P, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative Radiation Therapy for Locally Advanced Primary and Recurrent Colorectal Cancer: Ten-year Institutional Experience. Int J Radiat Oncol Biol Phys 84(3S):S345, 2012.
8. Skinner HD, Javle MM, Wolff RA, Clemons MV, Munsell MF, Delclos ME, Fleming JB, Das P, Crane CH, Krishnan S. Phase I trial of radiotherapy with concurrent bevacizumab, erlotinib, and capecitabine for locally advanced pancreatic cancer. J Clin Oncol 30 (Suppl 4):Abstr 254, 2012.
9. Das P, Eng C, Rodriguez-Bigas MA, Chang GJ, Skibber JM, Maru D, Munsell MF, Clemons MV, Kopetz S, Garrett CR, Shureiqi I, Krishnan S, Delclos ME, Crane CH. Preoperative radiation therapy with concurrent capecitabine, bevacizumab, and erlotinib for rectal adenocarcinoma: A phase I trial. J Clin Oncol, 2012.
10. Mitchell MP, Abboud M, Crane CH, Eng C, Chang GJ, Rodriguez-Bigas MA, Skibber JM, You YN, Krishnan S, Delclos ME, Das P. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancer: A large single-institution experience. J Clin Oncol, 2012.
11. Krishnan S, Delclos ME, Das P. Intensity-Modulated Radiation Therapy with Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma. Int J Radiat Oncol Biol Phys. e-Pub 2011.
12. Kelly P, Das P, Pinnix CC, Beddar S, Briere T, Pham M, Krishnan S, Delclos ME, Crane CH. Duodenal Toxicity after Fractionated Chemoradiation for Unresectable Pancreatic Cancer. Int J Radiat Oncol Biol Phys 81:S70, 2011.
13. Patel CB, Kattepogu KM, Park IJ, Eng C, Delclos ME, Feig BW, Crane CH, Skibber JM, Das P, Rodriguez-Bigas MA, Krishnan S, Chang GJ. Impact of preoperative radiation dose escalation on pathologic outcomes and radiation toxicity in locally advanced rectal cancer (LARC): A matched-pair analysis. J Clin Oncol 29:e14036, 2011.
14. Mok H, Crane CH, Briere T, Beddar S, Delclos ME, Krishnan S, Das P. Intensity-modulated radiation therapy (IMRT): Differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma. J Clin Oncol 29 (Suppl 4):Abstr 586, 2011.
15. Abboud MT, Crane C, Javle M, Kaseb A, Haque W, Delclos M, Krishnan S, Beddar S, Briere T, Das P. Risk factors for gastrointestinal bleeding in patients treated with radiation therapy for intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 81:S354, 2011.
16. Skinner HD, Sharp HJ, Kaseb AO, Javle MM, Vauthey J, Abdalla EK, Delclos ME, Das P, Crane CH, Krishnan S. Dose-escalated external beam radiotherapy in unresectable hepatocellular carinoma. J Clin Oncol 29 (Suppl 4):Abstr 267, 2011.
17. Heng L, Delclos ME, Briere TM, Beddar S, Das P, Krishnan S, Zhu X, Crane C. Comparison of Free Breathing versus Average 4D CT Image Data on External Beam radiotherapy Planning for Liver Tumors. Int J Radiat Oncol Biol Phys 78 (3 Suppl 1):S325(#2273), 2010.
18. Mok H, Briere TM, Martel MK, Beddar S, Delclos ME, Krishnan S, Crane CH, Das P. Comparative Analysis of Volumetric Modulated Arc Therapy (VMAT) vs. Intensity Modulated Radiation Therapy (IMRT) for Radiotherapy of Anal Carcinoma. Int J Radiat Oncol Biol Phys 78(3):S830, 2010.
19. Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere RM, Beddar AS, Mok H, Krishnan S, Delclos ME, Das P. Intensity Modulated Radiation Therapy (IMRT) with Concurrent Chemotherapy as Preoperative Treatment for Localized Gastric Adenocarcinoma. International Society for Gastrointestinal Oncology, 2010.
20. Haque W, Das P, Javle M, Kaseb A, Curley SA, Vauthey J-N, Abdalla EK, Delclos ME, Krishnan S, Crane CH. Radiation Therapy for intrahepatic cholangiocarcinoma. ISGIO, 2009.
21. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity modulated radiation therapy (IMRT) for the treatment of squamous cell anal cancer with para-aortic nodal involvement. ASCO Prog/Proc 2008 Gastrointestinal Cancers Symposium:317, 2008.
22. Reish AG, Das P, Eng C, Wolff RA, Beddar AS, Hodges JC, Delclos ME, Krishnan S. Intensity modulated radiation therapy (IMRT) for the treatment of patients with isolated recurrence from gastrointestinal adenocarcinoma. ASCO GI Cancers Symposium, Orlando, FL, 2008.
23. Gao S, Das P, O'Daniel J, Bouchard M, Briere TM, Delclos M, Krishnan S, Crane CH, Beddar S. A new technique to prevent target underdosage in anal cancer IMRT. AAPM, 2008.
24. Beddar AS, Gao S, O'Daniel J, Bouchard M, Briere T, Delclos ME, Krishnan S, Crane CH, Das P. Does an artificial structure decrease underdosage during intensity modulated radiation therapy (IMRT) planning for anal cancer?. ASTRO 2008, 2008.
25. Reish AG, Das P, Hodges JC, Eng C, Wolff RA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity Modulated Radiation Therapy (IMRT) for the treatment of patients with isolated recurrences from gastrointestinal adenocarcinomas. ASTRO, 2008.
26. Hodges JC, Das P, Eng C, Reish AG, Beddar AS, Delclos ME, Krishnan S, Crane CH. Intensity modulated radiation therapy (IMRT) for the treatment of squamous cell anal cancer with para-aortic nodal involvement. Int J Radiat Oncol Biol Phys 72(266S), 2008.
27. Das P, Cantor SB, Parker CL, Zampieri JB, Eng C, Delclos ME, Krishnan S, Janjan NA, Crane CH. Long-term quality of life after chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 72(104S), 2008.
28. Bourchard M, Briere TM, Beddar S, Das P, Delclos M, Krishnan S, Crane C. Practical guidelines for radiation treatment planning and dose constraints for gastro-intestinal cancers. AAPM, 2008.
29. Delclos M, Krishnan S, Mendoza T, Lin E, Vadhan-Raj S, Das P, Crane C, Zhang Y, Cleeland C, Janjan N. Baseline and temporal patterns of fatigue predict pathological response in patients treated with preoperative chemoradiation therapy for rectal cancer. J Clin Oncol 25(18S):626S (#14522), 2007.
30. Das P, Delclos ME, Skibber JM, Rodriguez-Bigas MA, Feig BW, Eng C, Bedi M, Krishnan S, Janjan NA, Crane CH. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Rad Oncol Biol Phys 69(277S), 2007.
31. Janjan NA, Wang XS, Mendoza T, Zhang Y, Das P, Crane C, Delclos M, Krishnan S. Utility of the M. D. Anderson Symptom Assessment Inventory (MDASI) for symptom evaluation during chemoradiation in patients with gastrointestinal malignancies. J Clin Oncol 25(18S):350S (#6613), 2007.
32. Crane CH, Ellis LM, Xiong HQ, O'Reilly M, Delclos ME, Abbruzzese JL, Evans DB, Pisters PWT, Wolff RA. Preliminary results of a phase I study of rhumab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. Eur J Cancer 1:S294 (#980), 2007.
33. Krishnan S, Mendoza T, Zhang Y, Wang XS, Das P, Delclos ME, Crane C, Cleeland C, Janjan J. Prevalence and temporal patterns of persistence of symptoms in 165 rectal cancer patients receiving preoperative chemoradiation therapy. J Clin Oncol 25(18S):713S (#19580), 2007.
34. Das P, Lin EH, Bhatia S, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ, Hoff PM, Eng C, Wolff RA, Delclos ME, Krishnan S, Janjan NA, Crane CH. Predictors of tumor response and downstaging in patients treated with preoperative chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys 66(Suppl):S167-S168 (#1067), 2006.
35. Reed V, Krishnan S, Bhosale P, Das P, Janjan N, Delclos M, Lowy A, Mansfield P, Ajani J, Crane C. Patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 66(Suppl):S271 (#2109), 2006.
36. Bhatia S, Krishnan S, Evans DB, Wolff RA, Delclos ME, Das P, Abbruzzese JL, Janjan N, Pisters P, Crane CH. Carcinoma of the ampulla of Vater treated with combined modality therapy: large single institution experience. 2006 Gastrointestinal Cancers Symposium, San Francisco, CA, 2006.
37. Rana V, Krishnan S, Evans D, Wolff R, Abbruzzese A, Varadhachary G, Delclos M, Das P, Janjan N, Crane C, Pisters P. Should All Patients With Ampullary Cancer Receive Adjuvant Therapy?. European Society of Therapeutic Radiology and Oncology, Leipzig, Germany, 2006.
38. Yu T-K, Das P, Bhosale PR, Iyer RB, Delclos ME, Krishnan S, Janjan NA, Crane CH. Patterns of locoregional recurrence and their predictors in rectal cancer patients treated with surgery and chemoradiation. Int J Radiat Oncol Biol Phys 63(Suppl):S12 (#20), 2005.
39. Beddar AS, Briere TM, Krishnan S, Delclos ME, Crane CH, Rodriguez-Bigas MA, Skibber JM, Gillin MT. Evaluation of Implantable MOSFET Dosimeters for Conventional and Intraoperative Radiation Therapy. 2005 AAPM Meeting Program, 2005.
40. Crane CH, Ellis LM, Xiong HQ, O'Reilly M, Delclos ME, Abbruzzese JL, Evans DB, Pisters PWT, Wolff RA. Preliminary results of a phase I study of rhumab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. European Journal of Cancer 1(5):S294 (#980), 2004.
41. Delclos M. RhuMab VEGF (Bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer: an active, well tolerated regimen. Int J Radiat Oncol Biol Phys 60(S1):S149, 2004.
42. Crane CH, Janjan NA, Feig BW, Vauthey JN, Brown TD, Curley S, Wolff RA, Ellis LM, Delclos M, Wong A, Phan T, Skibber J. Response to preoperative chemoradiation increases the use of sphincter preserving surgery in locally advanced low rectal cancer. Proceedings of the 84th Annual Meeting of the American Radium Society, 2002.
43. Crane CH, Janjan NA, Feig BW, Vauthey JN, Brown TD, Curley S, Wolff RA, Ellis LM, Delclos M, Wong A, Phan T, Skibber J. Response to preoperative chemoradiation increases the use of sphincter preserving surgery in locally advanced low rectal cancer. Proceedings of the European Society of Therapeutic Radiation and Oncology, Prague, CR, 2002.

Book Chapters

1. Janjan NA, Delclos ME, Crane CH, Krishnan S, Das P. The colon and rectum. In: Radiation Oncology. 9th. Elsevier: Philadelphia, PA, 560-605, 2009.
2. Crane CH, Delclos ME. Chemoradiation for localized pancreatic cancer. In: Advanced Therapy in Surgical Oncology. Decker Press: Hamilton, Ontario, 205-215, 2008.
3. Janjan N, Krishnan S, Das P, Gould MS, Zampieri J, Crane C, Delclos M, Cleeland C, Lutz ST, Chow E. Palliative Radiation Therapy Techniques. In: Cancer Pain Management. McGraw-Hill: US, 271-293, 2007.
4. Janjan NA, Lin EH, Delclos ME, Crane CH, Rodriguez-Bigas MA, Skibber JM. Rectal Cancer. In: M. D. Anderson Cancer Care Series Gastrointestinal Cancer. Springer, 137-164, 2005.
5. Janjan NA, Lin EH, Delclos ME, Crane CH, Rodriguez-Bigas MA, Skibber JM, Cleeland C. Palliative Radiotherapy. In: M.D. Anderson Cancer Care Series Gastrointestinal Cancer. Springer, 299-312, 2005.
6. Janjan NA, Skibber JM, Rodriguez-Bigas MA, Crane CH, Delclos ME, Lin EH, Ajani JA. Anal Cancer. In: M.D. Anderson Cancer Care Series Gastrointestinal Cancer. Springer, 246-270, 2005.
7. Janjan NA, Ballo M, Delclos M, Crane CH. The Colon and Rectum. In: Radiation Oncology: Rationale, Technique, Results. 8th. Mosby: St. Louis, MO, 497-536, 2003.
8. Janjan NA, Ballo M, Delclos M, Crane CH. Palliative Care. In: Radiation Oncology: Rationale, Technique, Results. 8th. Mosby: St. Louis, MO, 954-987, 2003.
9. Janjan NA, Ballo M, Delclos M, Crane CH. Anal Region. In: Radiation Oncology: Rationale, Technique, Results. 8th. Mosby: St. Louis, MO, 537-559, 2003.
10. Janjan NA, Delclos M, Ballo M, Crane CH. Palliative Radiotherapy. In: Cancer Pain: Assessment and Management. Cambridge University Press: Cambridge, UK,, 2003.
11. Janjan NA, Delclos M, Ballo M, Crane CH. Radiotherapy in treating gastrointestinal symptoms. In: Gastrointestinal Symptoms in Advanced Cancer Patients. Oxford University Press, 2002.